Clinical trials news, white papers, reports, and events from PharmaLeaders. New content daily, on our website and delivered right to your inbox.
Exclusive Interview with CEO of ePatientFinder, Tom Dorsett on Clinical Trials The following is an exclusive interview with the CEO of ePatientFinder, Tom Dorsett, discussing optimizing the recruitment process in clinical trials and how to avoid the unforeseen issues when submitting trials to the FDA. Interviewer: So why don’t you tell me a little bit about what your organization does from your viewpoint and what you hope ... Read More
TrialScope Launches Trial Results Summaries Portal TrialScope Launches Trial Results Summaries Portal TrialScope Partners with AstraZeneca to Enhance Patient Engagement JERSEY CITY, N.J., February 28, 2017 – TrialScope, the global leader in clinical trial transparency and compliance solutions, today announced the launch of the Trial Results Summaries Portal, a publicly accessible website where clinical trial sponsors can inform and educate trial participants and ... Read More
Questex Acquires ExL Events FOR IMMEDIATE RELEASE Questex Acquires ExL Events Acquisition of Leading Life Sciences Event Company Expands Company’s Services in Pharmaceutical, Life Science and Healthcare Markets NEWTON, Mass. (July 11, 2016) ─ Questex, a leading global business information and events company, today announced it has acquired ExL Events, Inc., expanding Questex’s presence in the global pharmaceutical, life science and healthcare ... Read More
Innovation Corner: Clinical Channel News Clinical Trials Recruitment Clinical Connect Delivers Outreach & Analytics SUMMARY Clinical Connect has access to 60+ million de-identified U.S. health histories that include diagnosis (ICD9/10) and treatment (CPT) data, lab and prescription information, financial and plan data, referral patterns and more. Data overlay of existing client data and inclusion/exclusion criteria help further refine searches. Data feeds are delivered directly ... Read More
Pediatric Gene Therapy The European approvals of Glybera® in 2012 and Strimvelis® in 2016 seem likely to be the vanguard of the therapeutic revolution heralded by the decoding of the human genome. Both of these treatments originated from academic centers of excellence and became the subjects of agreements with pharmaceutical companies (Uniqure/Chiesi and GSK, respectively) with the experience ... Read More
Can Better Relationships Improve Clinical Trials? A classic problem in clinical research has been patient awareness. That is one reason why the industry has turned to advertising to get the message about trials out to the patients. But that does not mean we are doing a better job of increasing awareness. Read More